RNF13-related severe early-onset epileptic encephalopathy Advocacy Hub | UniteRare

At a Glance

Live from database

1 event

Jun 2022

Ztalmy: FDA approved

Treatment of seizures associated with cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) in patients 2 years of age and older

FDAcompleted

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

1 program

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Patient Assistance Programs1

Ztalmy

Marinus Pharmaceuticals

OpenContact for details

No active clinical trials currently recruiting for RNF13-related severe early-onset epileptic encephalopathy.
Search all trials →

No recent news articles indexed yet for RNF13-related severe early-onset epileptic encephalopathy.
Search PubMed for RNF13-related severe early-onset epileptic encephalopathy →

No specialists currently listed for RNF13-related severe early-onset epileptic encephalopathy.

View Disease Page

Full profile, treatments, community

Search Clinical Trials

Find recruiting studies now

Find Specialists

Ranked by expertise & trials

Financial Assistance

Copay cards, PAPs, grants